Oil price moves from Israel-Iran conflict likely to dictate path of stocks – Citi
Oil price moves from Israel-Iran conflict likely to dictate path of stocks – Citi
Source link
Similar Posts
Artificial Intelligence to Have Great Impact on Indian Labour Market – Equitypandit
October 4, 2024October 4, 2024 India is facing some challenges, including geopolitical ones and the emerging artificial intelligence (AI) that might pose a threat to its prosperity despite the country’s credible economic performance. Union Finance Minister Nirmala Sitharaman said, “India must develop domestic capacity as it seeks to double…
Capacite Infra Shares Up 2% After Securing Order Worth Over Half Its Market Cap
September 18, 2025September 18, 2025 Shares of Capacite Infraprojects Ltd rose 2% to a day’s high of Rs 334 on 18th September. This happened after the company announced that it had secured an order worth Rs 1,518 crore for constructing ultra-luxury residential towers in Mumbai…
The Canadian Dividend Stock I Trust Most to Weather Any Kind of Market Storm
Dividend stocks are among the top investments for building a passive-income stream. However, difficult operating conditions or economic downturns could affect payouts. For instance, numerous Canadian companies either reduced or suspended payouts to preserve liquidity during the COVID-19 pandemic. More recently, even established income names such as BCE (TSX:BCE) have cut dividends in response to…
Is Power Corporation of Canada Stock a Buy for its 5% Dividend Yield?
Imagine a stock that’s not just another Canadian dividend payer but a consistent wealth-building machine that has delivered an astounding 2,840% total return over three decades. Meet Power Corporation of Canada (TSX:POW) stock — a Dividend Aristocrat that’s been quietly compounding investor wealth through thick and thin. Power Corporation of Canada offers a dividend yield…
Stocks to buy in 2025 for long term: Bajaj Auto, NYKAA among 5 stocks that could give 10-25% return – Brokerage Recommendations
Nuvama on NYKAA: Buy| Target Rs 285 (vs Rs 235)| LTP Rs 245| Upside 16% Nuvama on Nykaa: Nuvama has maintained a Buy rating on Nykaa and raised the target price to Rs 285 from Rs 235, indicating a 16% upside from the current level of Rs 245. (Disclaimer: Recommendations, suggestions, views, and opinions given…
Data Vantage: Hello Health, Lazada, CNV, Pine Labs and UangCermat in focus – shareandstocks.com
share this article! Healthtech company Hello Health has received funding from multi-family office Aument Capital Partners. Read More share this article! Source link
